Mereo BioPharma (MREO) Cash & Equivalents (2017 - 2026)
Mereo BioPharma (MREO) reported Cash & Equivalents of $30.12 million for Q2 2026, down 46.3% from $56.13 million a year earlier but up 0.1% from the prior quarter.
Powered by 
Analysis
Mereo BioPharma (MREO) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Mereo BioPharma posted Cash & Equivalents of $40.99 million, down 41.3% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 5.8% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $69.8 million in FY2024 (+21.6%), $57.42 million in FY2023 (-15.8%), $68.18 million in FY2022 (-46.4%) and $127.11 million in FY2021 (+310.2%).
- Five-year quarterly Cash & Equivalents spans a low of $30.1 million in Q1 2026 and a high of $127.11 million in Q4 2021.
- Year over year, Cash & Equivalents has now declined in each of the last five quarters, with an average decline of 23.6% over the last seven quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2021 (growth of 310.2%); the low point was Q1 2026 (a decline of 51.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $30.1 million (Q1 2026), $40.99 million (Q4 2025) and $48.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Mereo BioPharma | 44.55 Mn | -105.36 Mn | - | 30.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.12 Mn |
| Mar 31, 2026 | 30.10 Mn |
| Dec 31, 2025 | 40.99 Mn |
| Sep 30, 2025 | 48.70 Mn |
| Jun 30, 2025 | 56.13 Mn |
| Mar 31, 2025 | 62.50 Mn |
| Dec 31, 2024 | 69.80 Mn |
| Sep 30, 2024 | 80.52 Mn |
| Jun 30, 2024 | 87.43 Mn |
| Mar 31, 2024 | 48.70 Mn |
| Dec 31, 2023 | 57.42 Mn |
| Jun 30, 2023 | 53.12 Mn |
| Dec 31, 2022 | 67.92 Mn |
| Jun 30, 2022 | 92.71 Mn |
| Dec 31, 2021 | 127.28 Mn |
| Jun 30, 2021 | 152.40 Mn |
| Dec 31, 2020 | 31.99 Mn |
| Jun 30, 2020 | 69.95 Mn |
| Dec 31, 2019 | 21.44 Mn |
| Jun 30, 2019 | 35.86 Mn |
API Access
Mereo BioPharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MREO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MREO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MREO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();